Document Detail


Blood pressure response to an angiotensin II antagonist in thyrotoxic patients with and without high blood pressure.
MedLine Citation:
PMID:  7408785     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An angiotensin II antagonist, [sacrosine1, isoleucine8] angiotensin II, was infused into thyrotoxic patients. Blood pressure was monitored before and during the infusions to investigate whether the renin-angiotensin-aldosterone system was involved in the maintenance of blood pressure in normotensive and hypertensive thyrotoxic patients. Five out of 17 normotensive patients with hyperthyroidism showed more than a 10 mmHg decrease in mean blood pressure in response to the infusion (responders), while the remaining 12 patients showed no substantial change in blood pressure (non-responders). The infusion caused little change in blood pressure in 8 hyperthyroid patients with systolic hypertension. The mean levels of serum thyroxine, triiodothyronine, plasma renin activity and plasma aldosterone concentration in the normotensive responders were significantly higher than the values in the normotensive non-responders. There were no significant differences in these laboratory values between the hypertensive patients and the normotensive non-responders except that serum triiodothyronine levels were significantly higher in the hypertensive patients. The present study indicates that increased activity of the renin-angiotensin-aldosterone system is involved in the maintenance of blood pressure in most normotensive patients with severe hyperthyroidism, while hypertension in patients with hyperthyroidism is not angiotensin II dependent.
Authors:
T Ogihara; T Hata; A Maruyama; H Mikami; M Nakamaru; T Naka; Y Kumahara; K Kuma
Related Documents :
19812355 - The role of aldosterone in mediating the dependence of angiotensin hypertension on il-6.
9118515 - Remodeling of the left ventricle in primary aldosteronism due to conn's adenoma.
7149045 - Altered arterial ion transport and its reversal in aldosterone hypertensive rat.
18594485 - Endocrine arterial hypertension: therapeutic approach in clinical practice.
8269935 - Pressure-induced dissociation of ribosomes and elongation cycle intermediates. stabiliz...
759195 - Cardiovascular and respiratory effects of some anesthetics in the decerebrate rat.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Endocrinologia japonica     Volume:  27     ISSN:  0013-7219     ISO Abbreviation:  Endocrinol. Jpn.     Publication Date:  1980 Apr 
Date Detail:
Created Date:  1980-11-25     Completed Date:  1980-11-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0376546     Medline TA:  Endocrinol Jpn     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  223-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Sarcosine-8-Isoleucine Angiotensin II / diagnostic use,  pharmacology
Adolescent
Adult
Angiotensin II / antagonists & inhibitors*
Blood Pressure / drug effects*
Female
Humans
Hypertension / complications,  physiopathology*
Hyperthyroidism / complications,  physiopathology*
Male
Middle Aged
Chemical
Reg. No./Substance:
11128-99-7/Angiotensin II; 9088-01-1/1-Sarcosine-8-Isoleucine Angiotensin II

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A possible function of thiols, including glutathione, as cofactors in the conversion of thyroxine to...
Next Document:  Lipolytic activities other than lipoprotein lipase in mouse mammary gland.